Types of Systematic Reviews Explained: Systematic, Scoping, Rapid, Umbrella and Living Reviews
Systematic, scoping, overview, rapid and living are useful labels, but they do not all tell you the same thing about a review. Systematic and scoping reviews differ principally in what the synthesis is trying to accomplish. An overview of reviews changes the main unit of evidence from primary studies to existing systematic reviews. Rapid describes a way of accelerating evidence synthesis under a time-sensitive decision context. Living describes a way of maintaining a synthesis as new evidence appears. Once these distinctions are kept separate, many apparent arguments about “review type” become easier to resolve.
This is more than a terminological preference. A 2025 methodological overview explicitly distinguishes evidence-synthesis types from rapid and living modes that can be applied to different types of synthesis.1 The 2024 update to Right Review likewise reflects the difficulty of treating all named synthesis approaches as mutually exclusive boxes.2 The practical implication is that a researcher should ask at least three different questions: What base synthesis architecture fits the purpose? Does the decision context justify a rapid mode? Does the evidence need to be maintained in living mode?
Five familiar labels, three different kinds of decision
A systematic review uses explicit, pre-specified methods to answer a defined evidence question. The exact methods change with the question. Intervention-effect reviews, diagnostic-test-accuracy reviews, prevalence reviews and prognosis reviews are not interchangeable merely because all are systematic reviews. A scoping review is usually selected when the immediate job is to map concepts, evidence characteristics, methods or gaps rather than produce a focused inferential answer. JBI and Munn and colleagues make purpose central to that distinction.3,4
An overview of reviews, often called an umbrella review, changes something else: the review-level evidence unit. Cochrane describes systematic reviews as the unit of searching, inclusion and analysis for an overview.5 The label therefore carries consequences for eligibility criteria, appraisal and overlap that do not arise in the same way when primary studies are the unit of evidence.
Rapid and living are different again. The current evidence-synthesis types-and-modes framework treats rapid and living as modes that can be applied across synthesis types.1 Cochrane’s rapid-review work focuses on timely evidence production through deliberate methodological adaptations, while living-review guidance focuses on continual surveillance and timely incorporation of new evidence.6,7 Calling all five “types” in one flat list hides those differences.
The systematic-versus-scoping boundary is about purpose
The most persistent error in this comparison is to treat breadth as the rule. “Broad topic equals scoping review” is attractive because it is simple, but it fails as soon as a broad field contains a focused decision question. Munn and colleagues identify reasons for scoping review that include mapping the available evidence, clarifying concepts or definitions, examining how research has been conducted and identifying knowledge gaps.4 Those are purposes. They are not proxies for low study numbers, heterogeneity or inability to meta-analyze.
Suppose a team studies school-based physical-activity interventions across many ages, countries and delivery models. If the question is “What types of programs have been studied, how are they defined and where are the evidence gaps?”, the mapping purpose points toward scoping review. If the question is “What is the effect of school-based physical-activity programs on objectively measured activity compared with usual practice?”, the field can remain broad while the review purpose is inferential. A systematic review is then the more coherent starting point, although eligibility and planned subgroup analyses may need careful restriction.
The same reasoning applies when evidence is sparse. An effectiveness question with no eligible studies can produce an empty systematic review. Scarcity does not transform the question into a scoping question. Conversely, a large evidence base may still need a scoping review if the immediate goal is to understand how concepts, measures or study designs are distributed across the field.
No meta-analysis does not move a review into the scoping category
Meta-analysis is a synthesis technique. It is not the definition of systematic review. When studies are too clinically or methodologically different for a meaningful pooled estimate, a systematic review can use structured synthesis without meta-analysis. SWiM was developed to improve the reporting of such synthesis in systematic reviews of interventions.8 A team that changes the label to scoping review merely because pooling fails has changed the claimed purpose without changing the original question.
Critical appraisal is a consequence of purpose, not a badge of rigor
Systematic reviews that support inferential conclusions generally require critical appraisal appropriate to the included evidence. JBI scoping-review guidance does not make critical appraisal mandatory; teams may include it when it serves the review objective.3 This difference should not be translated into “systematic rigorous, scoping less rigorous.” A well-conducted scoping review is rigorous in relation to its mapping purpose. The error is using a mapping design to make conclusions that require a different appraisal and synthesis architecture.
| Same topic | Question actually being asked | More defensible starting point | Why |
|---|---|---|---|
| Digital mental-health apps | What app types, populations, outcomes and implementation settings have been studied? | Scoping review | The immediate job is to map the field and its characteristics. |
| Digital mental-health apps | Do app-based CBT interventions reduce depressive symptoms compared with control? | Systematic review | The purpose is a focused effect question even if the broader field is heterogeneous. |
| Vaccination hesitancy | How has vaccine hesitancy been defined and measured across populations? | Scoping review | Conceptual and measurement clarification is the target. |
| Vaccination hesitancy | What do patients’ accounts reveal about the meanings and experiences underlying hesitancy? | Qualitative evidence synthesis | Interpretive synthesis is required; a scoping review would only map the qualitative evidence. |
| New oncology treatment | Only three trials exist; what is the effect compared with standard care? | Systematic review | Small evidence volume does not change the inferential objective. |
The systematic-review versus overview boundary is about the evidence unit
An overview of reviews becomes methodologically attractive when the intended answer can be constructed from a body of existing systematic reviews. That requires more than the observation that many reviews exist. Cochrane’s Overview guidance asks authors to consider whether a new systematic review would be more appropriate and treats systematic reviews as the principal unit of searching, inclusion and analysis.5 PRIOR, which governs reporting rather than conduct, likewise requires authors to define what they mean by an eligible systematic review and report how overlap is handled.9
Several conditions can weaken the case for an overview. Existing reviews may be out of date. Their eligibility criteria may differ enough that apparent contradictions reflect different questions rather than different results. Review methods may be weak. One recent high-quality review may already answer most of the question. Important primary studies may have appeared after the reviews were completed. In these situations, updating a strong existing review or conducting a de novo systematic review can be methodologically cleaner than stacking another layer of synthesis on top of inadequate secondary evidence.
Overlap is a methodological problem, not a traffic-light veto
The same primary study can appear in several included systematic reviews. If overview authors ignore that dependence, the repeated study can exert more influence on the narrative or quantitative interpretation than its evidential contribution warrants. Citation matrices and the corrected covered area (CCA) are commonly used to describe this overlap. Weighted CCA, introduced in 2025, adds an informational perspective by weighting studies according to sample size.10
It would be a mistake, however, to turn a conventional CCA category such as “very high overlap” into an automatic design-rejection threshold. A 2026 meta-research study showed that CCA estimates can change materially according to matrix-construction assumptions such as scope, structural missingness and publication-thread handling.11 Overlap should therefore prompt methodological investigation. It may support excluding redundant reviews, selecting one review per comparison, using more sophisticated overlap management, or deciding that a de novo study-level synthesis is more interpretable. The number alone does not make that choice.
Rapid changes the conduct, not the question
A rapid review is often described colloquially as a “faster systematic review.” That description is incomplete. The speed comes from deliberate methodological decisions about scope, searching, screening, appraisal, synthesis or team organization. Cochrane’s 2024 rapid-review guidance contains 24 recommendations for rapid reviews of effectiveness and emphasizes tailoring methods to the review context rather than applying one fixed set of shortcuts.6 A separate methods paper addresses whether rapid review is appropriate before those adaptations are chosen.12
The critical boundary is the source of urgency. Rapid evidence synthesis developed to provide usable evidence within a condensed timeframe for decision-makers. A policy deadline, emergency response, HTA decision or guideline timetable can create that context. A student’s submission deadline is also a real constraint, but it does not automatically justify weakening or abbreviating review methods. Often the better response is to narrow the question, change the project scope or select a design whose purpose genuinely matches what can be completed.
There is also no universal six-month definition. Timeframes such as six months or less appear in rapid-review descriptions and organizational practice, but current methods literature treats timeliness in relation to decision needs rather than a single calendar cutoff.12 P28 therefore uses “rapid mode” to describe the conduct decision while retaining the underlying evidence-synthesis type.
Rapid scoping is now more than a hypothetical combination
The combination matters because it exposes the weakness of flat taxonomies. A 2025 paper in the Cochrane Rapid Reviews Methods Series provides specific guidance for rapid scoping, mapping and evidence and gap map reviews.13 A question may therefore have a scoping purpose and still require rapid conduct. The scoping purpose determines what the synthesis is for; rapid methods determine how the team adapts its conduct to the deadline. Detailed choices about which rapid adaptations to make belong in the Academy’s dedicated rapid-review planning resource rather than in this comparative guide.
Living changes the updating commitment
A living systematic review is continually updated as new evidence becomes available. PRISMA-LSR, published in 2024, is an add-on to PRISMA 2020 for reporting this continuing process.7 The underlying systematic-review question does not become a new question because the review moves into living mode. Instead, the team adds active surveillance, pre-specified incorporation decisions, versioning and communication of review status.
The choice to enter living mode should be selective. The question should matter to decision-makers. Current evidence should retain meaningful uncertainty. New evidence should be expected and have a realistic chance of changing conclusions. The team also needs enough capacity to keep the review alive. A review that is updated once after three years is an updated review, not automatically a living review. A review that claims living status but cannot maintain surveillance creates a different problem: the label suggests currency that the process no longer supports.
Search frequency is a protocol decision, not a universal slogan
Cochrane living-review resources have historically used frequent, often monthly searching in operational guidance. That should not be turned into a universal rule for every living evidence synthesis. The relevant principle is that surveillance must be frequent enough for the topic’s evidence velocity and decision consequences, and the chosen process must be reported transparently. PRISMA-LSR asks authors to report living methods and changes across iterations; it is a reporting extension, not a universal conduct timetable.7
Living reviews also need a stopping conversation
Living status is not necessarily permanent. Murad and colleagues proposed triggers for retiring a living systematic review, including situations in which the evidence has become sufficiently stable, new studies are unlikely to change the conclusion, the question loses priority or the resources required for continued maintenance are no longer available.14 These proposals help teams plan an exit, but they should not be presented as a validated universal retirement algorithm. A sensible protocol states how the team will revisit living status rather than assuming the review will remain living indefinitely.
Boundary cases are where labels become useful
A team is reviewing dozens of educational interventions delivered across age groups and countries. The literature is broad and heterogeneous. The question, however, asks whether a defined intervention class improves a specified learning outcome.
Decision: systematic review remains the starting point because the purpose is inferential. Heterogeneity should be handled through eligibility design, structured synthesis and, where justified, subgroup or sensitivity analysis. A scoping review could precede the systematic review if the team first needs to map the field, but it should not replace the systematic review merely because the topic is broad.
Researchers want to study “digital resilience,” but the term is used inconsistently and measures vary widely.
Decision: scoping review is a strong candidate because conceptual clarification is the immediate methodological problem. Once definitions and measures are understood, a later systematic review may be possible. The sequence matters: the scoping review answers a different first question rather than acting as a weaker version of the later review.
Several reviews address the same intervention, but they disagree. An overview sounds efficient.
Decision: first determine why the reviews disagree. If the difference is driven by eligibility criteria, dates, risk-of-bias decisions or duplicated primary studies, the overview has to make those differences visible. If most reviews are methodologically weak or outdated, a de novo or updated systematic review may produce a more interpretable answer. Conflict itself is not proof that another review layer is needed.
A ministry needs a decision brief on a defined intervention question before a scheduled policy vote.
Decision: rapid mode may be justified after the underlying base design is selected. If the question is focused and primary studies are the evidence unit, that may mean a rapid systematic review. If the purpose is still to map an emerging field, rapid scoping may fit better. The deadline does not answer the type question; it changes how the selected type may need to be conducted.
New trials are frequent and conclusions may change quickly.
Decision: living mode is plausible if current evidence is uncertain, the question is important enough to justify continuing updates and the team can maintain surveillance and analysis. If those resources are missing, a scheduled update may be more honest than claiming living status. Network meta-analysis may be part of the synthesis, but it remains an analytical architecture rather than a substitute for the review design.
A team asks what it is like for patients to live with a long-term treatment burden and how they interpret its effects on daily life.
Decision: qualitative evidence synthesis is the stronger family if interpretation is the objective. A scoping review would be reasonable only if the immediate purpose is to map the qualitative literature, concepts or methods. RETREAT can help a team choose among QES methods after that specialist route is recognized.15
What review labels commonly hide
Purpose-method mismatch
A scoping label can hide an effectiveness question that actually requires critical appraisal and inferential synthesis. A systematic-review label can hide an exploratory mapping aim that never needed that architecture.
Evidence-unit mismatch
An “umbrella review” can drift into de novo primary-study searching without acknowledging that the evidence unit has changed. Cochrane permits limited supplemental primary-study searching in specific circumstances but notes that it departs from the standard Overview format.5
Reporting-method confusion
PRISMA-ScR tells authors what to report about a scoping review; it does not tell them how to design the review protocol. PRIOR reports overviews; it does not replace Cochrane or JBI conduct guidance. PRISMA-LSR reports living review elements; it does not create the decision to enter living mode.7,9,16
Reporting standards do not decide the design
PRISMA 2020 remains the core reporting statement for systematic reviews. PRISMA-ScR is the published extension for scoping reviews, while an update remains under development as of 8 August 2026. PRIOR is the dedicated reporting guideline for overviews of reviews of healthcare interventions. PRISMA-LSR was finalized in 2024 as an add-on for living systematic reviews. A dedicated finalized PRISMA-RR extension is not yet available; the Cochrane Rapid Reviews Methods Group has published interim reporting guidance while extension development continues.7,9,16,17
This sequencing matters. Reporting standards should be chosen after the review architecture is known. Using the PRISMA-ScR checklist cannot make an effectiveness review into a scoping review. Using PRISMA 2020 cannot repair a review whose eligibility and synthesis methods do not answer its question. A checklist documents the method; it does not substitute for selecting the method.
Hybrids make sense when the layers are explicit
“Rapid scoping review” looks contradictory only if rapid and scoping are assumed to occupy the same taxonomic level. They do not need to. Current rapid-review methods guidance now specifically addresses rapid scoping, mapping and evidence and gap map reviews.13 A living systematic review is even more established: the systematic review provides the base methodology and living mode governs continued surveillance and updating.
Other combinations need more caution. Living network meta-analyses are well documented because network meta-analysis can be updated as part of a living systematic-review architecture. Living overviews have real examples, but dedicated methodological guidance is less standardized than for living systematic reviews. A page like P28 should therefore use such examples to explain combinability without pretending that every imaginable type-plus-mode combination already has a mature handbook.
How to use this reasoning before opening the decision tool
The paired review-design decision tool turns these boundaries into six orientation questions. It asks about purpose and evidence unit first. It then checks whether existing reviews are suitable for review-level synthesis, whether a genuine decision deadline supports rapid mode, whether living conditions are present and whether specialist methodology is needed.
The tool should be easiest to use after you can state your question without a review label. For example: “We need to estimate the effect of X on Y,” “We need to map how X has been defined and studied,” or “We need to synthesize the conclusions of existing systematic reviews about X.” If the sentence begins with “I want to do a scoping review because…”, rewrite it. The reason should survive even if the label is removed.
Frequently asked questions
Is a scoping review a type of systematic review?
Terminology varies. Scoping reviews use systematic and transparent methods, but current evidence-synthesis frameworks commonly distinguish scoping reviews within a broader “big picture” evidence-synthesis family rather than treating them as simply a conventional systematic review with fewer steps.1,3 The practical issue is to define the purpose and method clearly rather than rely on a contested hierarchy.
Can a systematic review be broad?
Yes. Breadth alone does not determine the design. If the review still asks a defined inferential question and uses methods appropriate to that question, a systematic review may be justified. The team may need narrower eligibility or planned heterogeneity analyses, but “broad” does not automatically mean “scoping.”
Can a scoping review include critical appraisal?
Yes. JBI does not make critical appraisal mandatory for scoping reviews, but it may be included when it serves the purpose of the review.3 If appraisal is being added to support strong conclusions about effectiveness or certainty, however, reconsider whether the underlying question belongs in a systematic-review design.
Are umbrella reviews and overviews of reviews exactly the same?
They are often used for closely related review-of-reviews methods, but terminology is not perfectly standardized across organizations and disciplines. This guide uses “overview of reviews (umbrella review)” and defines the method by the review-level evidence unit rather than assuming the label alone is enough.
Does very high CCA mean I should abandon an overview?
No automatic threshold should make that decision for you. CCA helps describe overlap, and traditional categories can help interpretation, but overlap depends on how the evidence matrix is constructed. Investigate the duplicated evidence, question alignment and planned handling strategy before deciding whether an overview remains interpretable.10,11
Is a rapid review less rigorous than a systematic review?
Can a scoping review be rapid?
Yes. Current methods guidance specifically addresses rapid scoping, mapping and evidence and gap map reviews.13 The mapping purpose remains; rapid methods modify how the work is conducted.
When should a review become living?
Living mode is most defensible when the question is high priority, evidence remains uncertain, consequential new evidence is expected and the team can sustain surveillance and updating. The exact cadence and update process should be specified rather than assumed.
Can a living systematic review stop being living?
Yes. Retirement triggers have been proposed for situations such as evidence stabilization, reduced priority, low likelihood of consequential new evidence or inability to sustain maintenance.14 These triggers guide judgment rather than provide a universally validated stopping formula.
Related methodology
The design is defensible when the reasoning is visible
Systematic, scoping and overview reviews differ because they are built to do different methodological jobs. Rapid and living modes add separate decisions about time and maintenance. Keeping those layers explicit prevents convenience, terminology or reporting checklists from choosing the review on the researcher’s behalf.
If the label changes when you clarify the purpose or evidence unit, that is not a failure. It is exactly what design selection is supposed to reveal.
References
- Nussbaumer-Streit B, Booth A, Garritty C, Hamel C, Munn Z, Tricco AC, Pollock D. Overview of evidence synthesis types and modes. J Clin Epidemiol. 2025;187:111970. https://doi.org/10.1016/j.jclinepi.2025.111970
- Clyne B, Sharp MK, O’Neill M, et al. An international modified Delphi process supported updating the web-based “Right Review” tool. J Clin Epidemiol. 2024;170:111333. https://doi.org/10.1016/j.jclinepi.2024.111333
- JBI. JBI Manual for Evidence Synthesis. Adelaide: JBI; current online manual. JBI Manual for Evidence Synthesis
- Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018;18:143. https://doi.org/10.1186/s12874-018-0611-x
- Pollock M, Fernandes RM, Becker LA, Pieper D, Hartling L. Chapter V: Overviews of Reviews. In: Higgins JPT, Thomas J, Chandler J, et al, editors. Cochrane Handbook for Systematic Reviews of Interventions. Cochrane. Cochrane Chapter V
- Garritty C, Hamel C, Trivella M, et al. Updated recommendations for the Cochrane rapid review methods guidance for rapid reviews of effectiveness. BMJ. 2024;384:e076335. https://doi.org/10.1136/bmj-2023-076335
- Akl EA, Khabsa J, Iannizzi C, et al. Extension of the PRISMA 2020 statement for living systematic reviews (PRISMA-LSR): checklist and explanation. BMJ. 2024;387:e079183. https://doi.org/10.1136/bmj-2024-079183
- Campbell M, McKenzie JE, Sowden A, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ. 2020;368:l6890. https://doi.org/10.1136/bmj.l6890
- Gates M, Gates A, Pieper D, et al. Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement. BMJ. 2022;378:e070849. https://doi.org/10.1136/bmj-2022-070849
- Ying X, Bougioukas KI, Pieper D, Mayo-Wilson E. Weighted corrected covered area (wCCA): a measure of informational overlap among reviews. Res Synth Methods. 2025;16(4):701-708. https://doi.org/10.1017/rsm.2025.19
- Bracchiglione J, et al. Impact of matrix-construction assumptions on quantitative overlap assessment in overviews: a meta-research study. Res Synth Methods. 2026. Publisher record
- Garritty C, Tricco AC, Smith M, et al. Rapid reviews methods series: assessing the appropriateness of conducting a rapid review. BMJ Evid Based Med. 2025;30(1):55-60. https://doi.org/10.1136/bmjebm-2023-112722
- Campbell F, Sutton A, Pollock D, Garritty C, Tricco AC, Schmidt L, Khalil H. Rapid reviews methods series: guidance on rapid scoping, mapping and evidence and gap map (‘Big Picture Reviews’). BMJ Evid Based Med. 2025;30(4):268-275. https://doi.org/10.1136/bmjebm-2023-112389
- Murad MH, Wang Z, Chu H, et al. Proposed triggers for retiring a living systematic review. BMJ Evid Based Med. 2023;28(5):348-352. https://doi.org/10.1136/bmjebm-2022-112100
- Booth A, Noyes J, Flemming K, et al. Structured methodology review identified seven (RETREAT) criteria for selecting qualitative evidence synthesis approaches. J Clin Epidemiol. 2018;99:41-52. https://doi.org/10.1016/j.jclinepi.2018.03.003
- Tricco AC, Lillie E, Zarin W, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467-473. https://doi.org/10.7326/M18-0850
- Stevens A, et al. Rapid reviews methods series: interim guidance for the reporting of rapid reviews. BMJ Evid Based Med. 2025;30(2):118-125. https://doi.org/10.1136/bmjebm-2024-112899
